nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.11.2014 | Original Paper

Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders

verfasst von: Sandra Van der Auwera, Deborah Janowitz, Andrea Schulz, Georg Homuth, Matthias Nauck, Henry Völzke, Matthias Rose, Henriette Meyer zu Schwabedissen, Harald Jürgen Freyberger, Hans Jörgen Grabe

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Depressive disorders are influenced by a complex interplay between genetic and environmental factors. Multiple studies support a role of serotonergic pathways in the pathophysiology of depressive disorders. As a rate-limiting enzyme of serotonin synthesis in the brain, tryptophan hydroxylase 2 (TPH2) represents a plausible candidate gene. This also applies to the serotonin reuptake transporter (5-HTTLPR) regulating the availability of serotonin in the synaptic gap. We hypothesize that functional polymorphisms (TPH2: rs7305115, 5-HTTLPR and rs25531) within both genes contribute to the risk of depressive disorders after childhood abuse in adult life. To confirm our results, we investigated two independent samples of Caucasian subjects from the study of health in Pomerania (SHIP–LEGEND: n = 2,029 and SHIP–TREND-0: n = 2,475). Depression severity was assessed by the Beck depression inventory (BDI-II) for LEGEND and the patient health questionnaire (PHQ-9) for TREND-0. Childhood abuse was assessed by the childhood trauma questionnaire. Rs7305115 (TPH2) revealed significant effects in SNP × abuse and SNP × SNP as well as in the three-way interaction. This three-way interaction among abuse, TPH2 and 5-HTTLPR showed a significant effect on depression score (p = 0.023). The SS genotype of 5-HTTLPR was associated with increased depression scores after childhood abuse only in carriers of the low-expression TPH2 GG genotype, whereas the TPH2 AA genotype reversed this effect. Our results support the role of interaction effects of genetic variants within serotonergic pathways. Genetic variants that may decrease the presynaptic serotonin concentration were associated with increased adult depressive symptoms in subjects with childhood abuse.

Nur mit Berechtigung zugänglich

Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, vanOs J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655–679PubMedCrossRef

Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157(10):1552–1562PubMedCrossRef

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium et al (2012) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18(4):497–511

Hek K, Demirkan A, Lahti J, Terracciano A, Teumer A et al (2013) A genome-wide association study of depressive symptoms. Biol Psychiatry 73(7):667–678PubMedCrossRef

Zill P, Baghai TC, Zwanzger P, Schüle C, Eser D, Rupprecht R, Möller HJ, Bondy B, Ackenheil M (2004) SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 9(11):1030–1036PubMedCrossRef

Gao J, Pan Z, Jiao Z, Li F, Zhao G, Wei Q, Pan F, Evangelou E (2012) TPH2 gene polymorphisms and major depression-a meta-analysis. PLoS One. doi:10.1371/0036721

Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76PubMedCrossRef

Jacobsen JPR, Medvedev IO, Caron MG (2012) The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2^Arg 439^Hisknockin mouse. Phil Trans Soc B 367:2444–2459CrossRef

Widom CS, DuMont K, Czaja SJ (2007) A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grownup. Arch Gen Psychiatry 64(1):49–56PubMedCrossRef

10.

Heim C, Binder EB (2012) Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 233:102–111PubMedCrossRef

11.

Edwards VJ, Holden GW, Felitti VJ, Anda RF (2003) Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry 160:1453–1460PubMedCrossRef

12.

Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF (2004) Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 82:217–225PubMedCrossRef

13.

Kendler KS, Eaves LJ (1986) Models for the joint effect of genotype and environment on liability to psychiatric illness. Am J Psychiatry 143(3):279–289PubMed

14.

Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA (1995) Genetic-environmental interaction in the genesis of aggressivity and conduct disorders. Arch Gen Psychiatry 52(11):916–924PubMedCrossRef

15.

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2004) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389CrossRef

16.

Grabe HJ, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Appel K, Barnov S, Nauck M, Schomerus G, Rosskopf D, Biffar R, John U, Völzke H, Freyberger HJ (2012) Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample. Am J Med Genet B Neuropsychiatr Genet 159B(3):298–309PubMedCrossRef

17.

Fergusson DM, Horwood LJ, Miller AL, Kennedy MA (2011) Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study. Br J Psychiatry 198(2):129–135PubMedCrossRefPubMedCentral

18.

Lim JE, Pinsonneault J, Sadee W, Saffen D (2007) Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry 12:491–501PubMed

19.

Grohmann M, Hammer P, Walther M, Paulmann N, Büttner A, Eisenmenger W, Baghai TC, Schüle C, Rupprecht R, Bader M, Bondy B, Zill P, Priller J, Walther DJ (2010) Alternative splicing and extensive RNA editing of human TPH2 transcripts. PLoS One. doi:10.1371/0008956 PubMedPubMedCentral

20.

Zhang Y, Zhang C, Yuan G, Yao J, Cheng Z, Liu C, Liu Q, Wan G, Shi G, Cheng Y, Ling Y, Li K (2010) Effect of tryptophan hydroxylase 2 rs7305115 SNP on suicide attempt risk in major depression. Behav Brain Funct 25:6–49

21.

Xu Z, Zhang Z, Shi Y, Pu M, Yuan Y, Zhang X, Li L, Reynolds GP (2012) Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. J Psychopharmacol 26:349–359PubMedCrossRef

22.

Herrmann MJ, Huter T, Müller F, Mühlberger A, Pauli P, Reif A, Renner T, Canli T, Fallgatter AJ, Lesch KP (2007) Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex 17(5):1160–1163PubMedCrossRef

23.

ZhengS YuM, Lu X, Huo T, Ge L, Yang J, Wu C, Li F (2010) Urinary metabolomics study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta 411(3–4):204–209CrossRef

24.

Zhang F, Jia Z, Gao P, Kong H, Li X, Lu X, Wu Y, Xu G (2010) Metabolomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry. Mol Biosyst 6(5):852–861PubMedCrossRef

25.

Oreland L, Nordquist N, Hallman J, Harro J, Nilsson KW (2010) Environment and the serotonergic system. Eur Psychiatry 25:304–306PubMedCrossRef

26.

John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C (2001) Study of health in pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 46:186–194PubMedCrossRef

27.

Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wallaschofski H, Nauck M, Frick S, Arnold A, Junger M, Mayerle J, Kraft M, Lerch MM, Dorr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B, Glaser S, Ewert R, Fietze I, Penzel T, Doren M, Rathmann W, Haerting J, Hannemann M, Ropcke J, Schminke U, Jurgens C, Tost F, Rettig R, Kors JA, Ungerer S, Hegenscheid K, Kuhn JP, Kuhn J, Hosten N, Puls R, Henke J, Gloger O, Teumer A, Homuth G, Volker U, Schwahn C, Holtfreter B, Polzer I, Kohlmann T, Grabe HJ, Rosskopf D, Kroemer HK, Kocher T, Biffar R, John U, Hoffmann W (2011) Cohort profile: the study of health in Pomerania. Int J Epidemiol 40:294–307CrossRef

28.

Beck AT, Steer RA (1987) Beck Depression Inventory-Manual. The Physiological Corporation, San Antonio

29.

Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613PubMedCrossRefPubMedCentral

30.

Wahl I, Löwe B, Bjorner JB, Fischer F, Langs G, Voderholzer U, Aita SA, Bergemann N, Brähler E, Rose M (2014) Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol 67:73–86PubMedCrossRef

31.

Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Strokes J, Handelsman L, Medrano M, Desmond D et al (2003) Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl 27(2):169–190PubMedCrossRef

32.

Wingenfeld K, Spitzer C, Mensebach C, Grabe HJ, Hill A, Gast U, Schlosser N, Höpp H, Beblo T, Driessen M (2010) The german version of the childhood trauma questionnaire (CTQ):Preliminary Psychometric Properties. Psychother Psychosom Med Psychol 60(11):442–450PubMedCrossRef

33.

Schulz, A., Becker, M., Barnow, S., Appel, K., Mahler, J., Schmidt, C.O., John, U., Freyberger, H.J., Grabe, H.J. (2014). The impact of childhood trauma on depression: does resilience matter?. J Psychosom Res, accepted for puplication

34.

Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U et al (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect 102:247–254PubMedCrossRef

35.

Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826PubMedCrossRefPubMedCentral

36.

Perroud N, Salzmann A, Saiz PA, Baca-Garcia E, Sarchiapone M, Garcia-Portilla MP et al (2010) Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder. Am J Med Genet B Neuropsychiatr Genet 153B:1494–1497PubMedCrossRef

37.

Harrell FE Jr (200) Regression Modeling Strategies.With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer, New York, p 596

38.

Hosmer DW, Lemeshow S (2000) Applied Logistic Regression, 2nd edn. Wiley, New York, p 392CrossRef

39.

Greenland S (2008) Introduction to regression models. In: Rothman KJ, Greenland S, Lash TL (eds) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 381–417

40.

Persons JB, Perloff JM (1989) The relationship between attributions and depression varies across attributional dimensions and across samples. J Psychophathol Behav Assess 11:47–60CrossRef

41.

Keller MC (2014) Gene-environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry 75:18–24PubMedCrossRef

42.

Luca C, Shern L, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that effect splicing. Nat Rev 3:285–298CrossRef

43.

Homberg JR, Lesch KP (2011) Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 69:513–519PubMedCrossRef

44.

Neumeister A, Hu X, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS (2006) Differential Effects of 5-HTTLPR Genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63:978–986PubMedCrossRef

45.

Janssens AC, van Duijn CM (2009) Genome-based prediction of common diseases: methodological considerations for future research. Genome Med. doi:10.1186/gm20 PubMedPubMedCentral

46.

Booij L, Wang D, Lévesque ML, Tremblay RE, Szyf M (2013) Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress – diathesis model of depression. Phil Trans R Soc B 368:20120251PubMedCrossRefPubMedCentral

47.

Vijayendran M, Beach SR, Plume JM, Brody GH, Philibert RA (2012) Effects of genotype and child abuse on DNA methylation and gene expression at the serotonin transporter. Front Psychiatry. doi:10.3389/fpsyt.2012.00055 PubMedPubMedCentral

48.

Ghaemi SN, Vöhringer PA (2011) The heterogeneity of depression: an old debate renewed. Acta Psychiatr Scand 124(6):497PubMedCrossRef

49.

Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, Penninx BW (2011) Identifying depressive subtypes in a large cohort study: results from the netherlands study of depression and anxiety (NESDA). J Clin Psychiatry 71(12):1582–1589CrossRef

50.

Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW (2013) Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18(6):692–699PubMedCrossRef

Titel: Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders
verfasst von: Sandra Van der Auwera
Deborah Janowitz
Andrea Schulz
Georg Homuth
Matthias Nauck
Henry Völzke
Matthias Rose
Henriette Meyer zu Schwabedissen
Harald Jürgen Freyberger
Hans Jörgen Grabe
Publikationsdatum: 01.11.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe Sonderheft 1/2014
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-014-0536-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2014

A perfect match: noninvasive brain stimulation and psychotherapy

Selected issues of the DGPPN Congress in 2013

Prediction and prevention of psychosis: current progress and future tasks

Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease